PaulMartinettiMD

Summary

• Paul Martinetti, MD, is a seasoned Clinical Trials Technology Consultant with a consistent history of innovation and accomplishment in clinical research, as demonstrated by his 15 years as the Principal of Digital Science Technologies LLC. His career is marked by a dedication to enhancing clinical trial design and execution, particularly in the areas of cancer survivorship and dermatology. As an expert in developing, validating, and training on clinical trial efficacy assessment scales and endpoints, he has devised user-friendly disease severity grading tools employed in over 50 dermatology clinical studies across 20 countries. Martinetti's commitment to driving clinical trial success is further demonstrated by his impressive 98% overall study success rate and a 90%+ repeat business rate in investigator training.
  
  Dr. Martinetti's leadership extends to securing over $4 million in NIH grants to fund impactful physician and patient education web interventions. He excels in KOL/expert relationship management, exemplified by his collaborations with leading researchers on the nationally recognized "Second Manhood" project examining cancer survivorship and male reproductive dysfunction. His work on this project, conducted in tandem with the University of Texas MD Anderson Cancer Center (UT MDACC) and the US National Cancer Institutes, underscores his ability to forge and leverage impactful partnerships in the field. Furthermore, his publication record, including contributions to esteemed journals such as the Journal of the National Comprehensive Cancer Network, solidify his standing as a thought leader in clinical research.
  
  Dr. Martinetti possesses a strong command of digital technology and its applications in enhancing patient and clinical research user experiences, clinical trials workflow, and data management. He programs regularly in a half dozen modern software and hardware languages to manipulate and analyze data and improve workflows.